Disagreements Within the US Food and Drug Administration Regarding Approval of Novel Therapeutic Agents, 2011-2015.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 32706379.
- Also identified by DOI 10.1001/jamanetworkopen.2020.9498 and PMC identifier 7382003.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study examines the frequency of disagreements within the US Food and Drug Administration (FDA) regarding approval of novel therapeutic agents.
Medical subject headings
- Drug Approval
- Legislation, Drug
- Pharmaceutical Preparations
- Product Surveillance, Postmarketing
- United States Food and Drug Administration